GlassScriptPhysician profile
Maureen Sloan
NPI 1861412660
$953.36
in general payments reported to CMS, 2019-2025
7 companies · $17.64 in 2025
The $17.64 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $285 · 2024: $651 · 2025: $17.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Education: $76.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.25 |
| Education | $76.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $353.94 | 2023-2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $143.09 | 2024 | Cobenfy |
| Supernus Pharmaceuticals, INC. | $125.95 | 2023 | Qelbree |
| Vanda Pharmaceuticals INC. | $125.00 | 2024 | Fanapt |
| Neurocrine Biosciences, INC. | $122.17 | 2024 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.57 | 2023-2024 | Caplyta |
| Lundbeck LLC | $17.64 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.